Impact of nutrition clinic on obesity in Baghdad, Iraq: First year outcome

Hayyawi, Ali Hassan; Hasan, Khalid; Lafta, Riyadh

doi:10.4103/2347-2618.197703

Cited by 2 publications

(1 citation statement)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For instance, the prevalence of obesity in the United State is about 20%-25%, while in Europe it reaches 10%-25% [4]. In Iraq, data on obesity is limited and not representative of the community [5], although some investigators have shown that the prevalence of overweight and obesity is 55.1% and 43.7% in Basrah and Baghdad, respectively [5,6]. The physiological mechanisms of obesity include the nutritional status, environmental conditions, and genetic background [7].…”

Section: Introductionmentioning

confidence: 99%

The association between Toxoplasma gondii seropositive status and diabetes mellitus in obese and non-obese subjects in Baghdad

Al-Khafajii

Al-Warid

Al-Abbudi

2021

eijs

View full text Add to dashboard Cite

Anti-Toxoplasma gondii seropositive status among obese and diabetic patients has recently attracted substantial attention. The objective of this study was to assess the seropositive rate of T. gondii and its relation to high body mass index (BMI), diabetes, and metabolic syndrome among participants (n=100) who attended Al-Kadhimiya Teaching Hospital, Baghdad-Iraq. An observational analytical study was conducted from October 2019 to March 2020. Participants were divided into three groups based on their BMI; obese (n=38), overweight (n=32) and normal (n=30). In addition, they were divided into diabetic (n=45) and non-diabetic (n=55) based on clinical examination, laboratory examination, and medical interview. Another classification was considered: Obese-diabetic (n=24), obese- non-diabetic (n=14), overweight-diabetic (n=13), overweight non-diabetic (n=19), normal-diabetic (n=8) and normal-nondiabetic (n=28). Finally, participants were divided into metabolic syndrome-positive (n=64) and metabolic syndrome negative (n=36). Serum samples were taken from all participants and examined for the detection of anti-T.gondii IgG and IgM antibodies. The anti T.gondii IgG positive rate was higher in the “overweight” compared to the “obese” and “normal BMI” groups. No significant differences (P=0.22) in seropositive rate were indicated among groups. The results also showed that there was no significant difference (P=0.84) in anti-T. gondii IgG positive rate between diabetic and non-diabetic patients. While the anti T.gondii IgG was significantly (P=0.03) higher in patients with metabolic syndrome as opposed to those with no metabolic syndrome. The results also showed that normal-diabetic and overweigh-diabetic patients had the highest anti-T.gondii IgG positive rate, although no significant differences were noticed among groups. Some other parameters were also examined for the participants, including abdominal obesity, cholesterol, triglycerides, high density lipoprotein (HDL), very low density lipoprotein (VLDL), glucose and glycated haemoglobin. Significant differences were noticed only for abdominal obesity and HDL (P˂0.05) between anti T.gondii IgG positive cases and anti T.gondii IgG negative cases. Other factors did not show significant differences between these two groups. Finally, this study showed that T. gondii seropositive status played a significant role in changing only HDL level while other parameters of lipid profile were not influenced by T.gondii seropositivity among obese, diabetic patients and metabolic syndrome patients.

show abstract

Section: Introductionmentioning

confidence: 99%

The association between Toxoplasma gondii seropositive status and diabetes mellitus in obese and non-obese subjects in Baghdad

Al-Khafajii

Al-Warid

Al-Abbudi

2021

eijs

View full text Add to dashboard Cite

show abstract

Prevalence of Obesity and Overweight among Adults in the Middle East Countries from 2000 to 2020: A Systematic Review and Meta-Analysis

et al. 2022

View full text Add to dashboard Cite

Background. Obesity has become a significant public health issue worldwide, and it is a major risk factor for many noncommunicable diseases. This systematic review aimed to identify the prevalence of obesity and overweight in the Middle East region and different countries in this region. Materials and Methods. PubMed, Google Scholar, and MEDLINE databases were searched from 2000–2020 to identify relevant studies in the Middle East area. The survey was carried out using combinations of Medical Subject Headings (Mesh) keywords like “body mass index”, “obesity”, “overweight”, “prevalence”, “Middle-East”, and “Countries in the Middle East area”. Analysis of the data was done using STATA-14, and a random-effects model was used to estimate the pooled prevalence. Results. A total of 101 studies with 698905 participants have been identified that met inclusion criteria for this meta-analysis. The pooled estimates of the prevalence of obesity and overweight in the Middle East area were 21.17 (95% CI: 17.05–26.29) and 33.14 (95% CI: 26.87–40.87), respectively. The findings showed that obesity prevalence increased with age so that the highest prevalence of obesity and overweight was observed in people >40 years old. Obesity prevalence in the Middle East area remained steady between 2000–2006 and 2014–2020 (23%). During these time intervals, the prevalence of overweight decreased from 34.83 (95% CI: 32.40–37.45) to 32.85 (95% CI: 31.39–34.38). Conclusions. Despite the relative stabilization of the overweight and obesity trend in the Middle East, current interventions to combat the overweight epidemic need to be maintained and strengthened because the prevalence of overweight and obesity in this region is still very high. The prevalence of obesity increases with age so that people over 40 have the highest percentage of obesity and overweight. Therefore, implementing intervention programs to prevent and control obesity and overweight in the Middle East is essential.

show abstract

Impact of nutrition clinic on obesity in Baghdad, Iraq: First year outcome

Cited by 2 publications

References 1 publication

The association between Toxoplasma gondii seropositive status and diabetes mellitus in obese and non-obese subjects in Baghdad

The association between Toxoplasma gondii seropositive status and diabetes mellitus in obese and non-obese subjects in Baghdad

Prevalence of Obesity and Overweight among Adults in the Middle East Countries from 2000 to 2020: A Systematic Review and Meta-Analysis

Contact Info

Product

Resources

About